Sinda Bigenzahn

781 total citations
16 papers, 603 citations indexed

About

Sinda Bigenzahn is a scholar working on Hematology, Immunology and Transplantation. According to data from OpenAlex, Sinda Bigenzahn has authored 16 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 9 papers in Immunology and 4 papers in Transplantation. Recurrent topics in Sinda Bigenzahn's work include Hematopoietic Stem Cell Transplantation (9 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (4 papers). Sinda Bigenzahn is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), T-cell and B-cell Immunology (8 papers) and Immune Cell Function and Interaction (4 papers). Sinda Bigenzahn collaborates with scholars based in Austria, United States and Switzerland. Sinda Bigenzahn's co-authors include Thomas Wekerle, Megan Sykes, Josef Kurtz, Ferdinand Muehlbacher, Zvonimir Koporc, Peter Blaha, Yasuo Takeuchi, Friedrich Wrba, Helga Bergmeister and Edgar Selzer and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Sinda Bigenzahn

16 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sinda Bigenzahn Austria 10 385 178 168 112 60 16 603
Christoph Klaus Austria 10 311 0.8× 184 1.0× 104 0.6× 50 0.4× 18 0.3× 20 493
Larry D. Bozulic United States 11 156 0.4× 130 0.7× 251 1.5× 157 1.4× 24 0.4× 21 501
NICHOLAS W. PEARCE Australia 8 489 1.3× 30 0.2× 129 0.8× 108 1.0× 46 0.8× 13 594
U Gross United States 6 198 0.5× 97 0.5× 107 0.6× 114 1.0× 28 0.5× 12 395
Debbie Dunnion United Kingdom 6 397 1.0× 133 0.7× 21 0.1× 15 0.1× 28 0.5× 8 512
Cariel Taylor United States 5 332 0.9× 40 0.2× 10 0.1× 102 0.9× 164 2.7× 5 471
Kristin Melli United States 4 566 1.5× 19 0.1× 30 0.2× 162 1.4× 336 5.6× 4 743
Sarah K. Nicholas United States 8 81 0.2× 17 0.1× 23 0.1× 62 0.6× 27 0.5× 20 259
Alexandros Kogimtzis United Kingdom 5 341 0.9× 12 0.1× 18 0.1× 77 0.7× 161 2.7× 6 462
In‐Cheol Baek South Korea 10 218 0.6× 31 0.2× 30 0.2× 21 0.2× 49 0.8× 74 379

Countries citing papers authored by Sinda Bigenzahn

Since Specialization
Citations

This map shows the geographic impact of Sinda Bigenzahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sinda Bigenzahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sinda Bigenzahn more than expected).

Fields of papers citing papers by Sinda Bigenzahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sinda Bigenzahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sinda Bigenzahn. The network helps show where Sinda Bigenzahn may publish in the future.

Co-authorship network of co-authors of Sinda Bigenzahn

This figure shows the co-authorship network connecting the top 25 collaborators of Sinda Bigenzahn. A scholar is included among the top collaborators of Sinda Bigenzahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sinda Bigenzahn. Sinda Bigenzahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bigenzahn, Sinda, B. Mahr, Johann Pratschke, et al.. (2017). No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients. Clinical & Experimental Immunology. 192(2). 233–241. 6 indexed citations
2.
Bigenzahn, Sinda, Ines Pree, Christoph Klaus, et al.. (2016). Minor Antigen Disparities Impede Induction of Long Lasting Chimerism and Tolerance through Bone Marrow Transplantation with Costimulation Blockade. Journal of Immunology Research. 2016. 1–9. 4 indexed citations
3.
Müller, Yannick D., Gang Mai, Philippe Morel, et al.. (2010). Anti-CD154 mAb and Rapamycin Induce T Regulatory Cell Mediated Tolerance in Rat-to-Mouse Islet Transplantation. PLoS ONE. 5(4). e10352–e10352. 39 indexed citations
4.
Klaus, Christoph, Sinda Bigenzahn, Nina Pilat, et al.. (2010). The role of natural killer T cells in costimulation blockade-based mixed chimerism. Transplant International. 23(11). 1179–1189. 8 indexed citations
5.
Blaha, Peter, Ruth Exner, Andrea Borgo, et al.. (2009). Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect Ratio. Breast Care. 4(3). 155–161. 2 indexed citations
6.
Gnant, Michael, Peter Blaha, Peter Dubsky, et al.. (2009). Review: Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?. Therapeutic Advances in Medical Oncology. 1(3). 123–136. 3 indexed citations
7.
Koporc, Zvonimir, Nina Pilat, Patrick Nierlich, et al.. (2008). Murine Mobilized Peripheral Blood Stem Cells Have a Lower Capacity than Bone Marrow to Induce Mixed Chimerism and Tolerance. American Journal of Transplantation. 8(10). 2025–2036. 13 indexed citations
8.
Linhart, Birgit, Sinda Bigenzahn, Arnulf Hartl, et al.. (2007). Costimulation Blockade Inhibits Allergic Sensitization but Does Not Affect Established Allergy in a Murine Model of Grass Pollen Allergy. The Journal of Immunology. 178(6). 3924–3931. 45 indexed citations
9.
Pree, Ines, Sinda Bigenzahn, Dietmar Fuchs, et al.. (2007). CTLA4Ig Promotes the Induction of Hematopoietic Chimerism and Tolerance Independently of Indoleamine-2,3-Dioxygenase. Transplantation. 83(5). 663–667. 31 indexed citations
10.
Koporc, Zvonimir, Sinda Bigenzahn, Peter Blaha, et al.. (2006). Induction of Mixed Chimerism through Transplantation of CD45-Congenic Mobilized Peripheral Blood Stem Cells after Nonmyeloablative Irradiation. Biology of Blood and Marrow Transplantation. 12(3). 284–292. 12 indexed citations
11.
Bigenzahn, Sinda, Peter Blaha, Zvonimir Koporc, et al.. (2005). The Role of Non-Deletional Tolerance Mechanisms in a Murine Model of Mixed Chimerism with Costimulation Blockade. American Journal of Transplantation. 5(6). 1237–1247. 77 indexed citations
12.
Blaha, Peter, Sinda Bigenzahn, Zvonimir Koporc, et al.. (2005). Short-Term Immunosuppression Facilitates Induction of Mixed Chimerism and Tolerance after Bone Marrow Transplantation without Cytoreductive Conditioning. Transplantation. 80(2). 237–243. 39 indexed citations
13.
Heitger, Andreas, Peter Blaha, Sinda Bigenzahn, Ferdinand Muehlbacher, & Thomas Wekerle. (2004). Influence of immunosuppressive drugs on cell-induced graft tolerance. Current Opinion in Organ Transplantation. 9(3). 307–313. 6 indexed citations
14.
Wekerle, Thomas, Peter Blaha, Zvonimir Koporc, et al.. (2003). Mechanisms of tolerance induction through the transplantation of donor hematopoietic stem cells: central versus peripheral tolerance. Transplantation. 75(Supplement). 21S–25S. 32 indexed citations
15.
Blaha, Peter, Sinda Bigenzahn, Zvonimir Koporc, et al.. (2003). The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood. 101(7). 2886–2893. 153 indexed citations
16.
Wekerle, Thomas, Josef Kurtz, Sinda Bigenzahn, Yasuo Takeuchi, & Megan Sykes. (2002). Mechanisms of transplant tolerance induction using costimulatory blockade. Current Opinion in Immunology. 14(5). 592–600. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026